Sandostatin LAR

Medicinal product

(Invented) name

Sandostatin LAR

Active substance (s)

Oktreotidas

Strength

20 mg

Pharmaceutical form

milteliai ir tirpiklis injekcinei suspensijai

Route (s) of administration

leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

H01CB02, Octreotide

Marketing authorisation holder

SIA Novartis Baltics, Latvija

Date of authorisation

2000-07-04

Date of renewal

2010-11-10

Documents

1033 Sandostatin LAR II PL 2024 10 09.docx

1033 Pakuotės lapelis LAR 2024 10 09.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

DE/H/5095/006

Marketing authorisation procedure

Savitarpio pripažinimo procedūra

Qualitative and quantitative composition

Flakone yra	1 vnt.
Oktreotidas	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
53081	67022	1067022	flakonas	miltelių flakonas su adapteriu, tirpiklio užpildytas švirkštas (2 ml) ir saugi injekcinė adata, N1		Receptinis	LT/1/94/1033/007	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2010-11-10	Perregistruotas
2000-07-04	Registruotas